Literature DB >> 4107265

Radioimmunoassay for measurement of triiodothyronine in human serum.

I J Chopra, D H Solomon, G N Beall.   

Abstract

A convenient, specific, precise, and reproducible radioimmunoassay system for measurement of triiodothyronine (T(3)) in human serum has been developed. The procedure compares the ability of standards and unknowns to compete with radioactive T(3) for binding sites on a T(3)-binding antiserum produced in rabbits by immunization with human thyroglobulin. The assay is set up in the presence of 250 ng thyroxine (T(4)) in all tubes, to mobilize T(3) from its binding with the thyronine-binding globulin (TBG), and athyreotic sheep serum in standards to correct for the TBG in the unknowns. The method regularly detected 0.4 ng T(3), which would correspond to a T(3) concentration of 100 ng/100 ml when 400 mul of serum is analyzed. The mean recovery of unlabeled T(3) added to normal serum pools was 106%. Serial dilution of hyperthyroid sera containing high concentrations of T(3) with athyreotic sheep serum yielded expected values. The serum T(3) concentration in 80% of 31 euthyroid normal subjects was less than 100 ng/100 ml (range < 100-170 ng/100 ml); it was greater than 170 ng/100 ml in 89% of 27 sera of hyperthyroid patients with untreated Graves' disease (range < 100-1300, mean 519 in 25 sera with detectable T(3)). The concentration of serum T(3) fell, frequently to undetectable levels, during treatment of hyperthyroid patients with antithyroid drugs. The serum T(3) concentration in four hypothyroid patients was less than 100 ng/100 ml.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4107265      PMCID: PMC292136          DOI: 10.1172/JCI106696

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Observations concerning the binding of thyroid hormones by human serum prealbumin.

Authors:  S H INGBAR
Journal:  J Clin Invest       Date:  1963-02       Impact factor: 14.808

2.  The physiologic activity of l-triiodothyronine.

Authors:  J LERMAN
Journal:  J Clin Endocrinol Metab       Date:  1953-11       Impact factor: 5.958

3.  Effect of 3:5:3'-L-triiodothyronine in myxoedema.

Authors:  J GROSS; R PITT-RIVERS; W R TROTTER
Journal:  Lancet       Date:  1952-05-24       Impact factor: 79.321

4.  Production of antibodies specifically binding triiodothyronine and thyroxine.

Authors:  I J Chopra; J C Nelson; D H Solomon; G N Beall
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

5.  The measurement of serum triiodothyronine by double column chromatography.

Authors:  J H Dussault; R Lam; D A Fisher
Journal:  J Lab Clin Med       Date:  1971-06

6.  Clinical evaluation of a new method for the determination of serum thyroxine.

Authors:  B E Murphy; C J Pattee; A Gold
Journal:  J Clin Endocrinol Metab       Date:  1966-03       Impact factor: 5.958

7.  An analysis of published data on thyroxine turnover in human subjects.

Authors:  T H Oddie; J H Meade; D A Fisher
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

8.  Total and free triiodothyronine in human serum.

Authors:  J A Nauman; A Nauman; S C Werner
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

9.  The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.

Authors:  K A Woeber; R J Sobel; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

10.  Thyroxine transport in thyrotoxicosis and hypothyroidism.

Authors:  M Inada; K Sterling
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

View more
  19 in total

1.  The radioimmunoassay of triiodothyronine and its clinical application.

Authors:  C J Eastman; J M Corcoran; R P Ekins; E S Williams; J D Nabarro
Journal:  J Clin Pathol       Date:  1975-03       Impact factor: 3.411

2.  Highlights in thyroidology: a historical vignette.

Authors:  Michael Weissel
Journal:  Wien Klin Wochenschr       Date:  2014-03-21       Impact factor: 1.704

3.  Unintentional thyrotoxicosis factitia due to a diet pill.

Authors:  G D Braunstein; R Koblin; M Sugawara; A E Pekary; J M Hershman
Journal:  West J Med       Date:  1986-09

4.  Radioimmunoassay of triiodothyronine in unextracted human serum.

Authors:  R D Hesch; D Evered
Journal:  Br Med J       Date:  1973-03-17

5.  Serum protein-bound iodine or total thyroxine.

Authors:  F Clark
Journal:  J Clin Pathol       Date:  1975-03       Impact factor: 3.411

6.  Recovery of serum TSH and thyroid hormones after 3'isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels.

Authors:  N A Salomon-Montavon; A G Burger
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

7.  Serum triiodothyronine determination in clinical use.

Authors:  J E Stafford; S Lees; D Watson
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

8.  Radioimmunoassay for measurement of thyroglobulin in human serum.

Authors:  A J Van Herle; R P Uller; N I Matthews; J Brown
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

Review 9.  The effects of drugs on tests of thyroid function.

Authors:  P H Davies; J A Franklyn
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.